Extendicare Announces Appointment of Michael Guerriere to Board of Directors
MARKHAM, ONTARIO, March 12, 2018 – Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) today announced the appointment of Michael Guerriere to its Board of Directors, effective immediately, for a term to expire at the next annual meeting of shareholders, whereupon he will stand for election. This appointment increases Extendicare’s board to ten directors.
Dr. Guerriere is Chief Medical Officer, Vice President and Chief Strategy Officer of TELUS Health, where he oversees the strategy for the company’s eHealth business which serves clinical professionals, hospitals, government agencies, health authorities, pharmacies and consumers across Canada. Prior to joining TELUS Health in 2011, Dr. Guerriere was a founding partner of Courtyard Group, an international healthcare consultancy that TELUS Health acquired. Before starting Courtyard in 2002, he served ten years as an executive in university teaching hospitals, including Executive Vice President and Chief Operating Officer at the University Health Network.
Dr. Guerriere has adjunct appointments in the Institute of Health Policy Management and Evaluation at the University of Toronto and the School of Health Information Science at the University of Victoria. He has served on numerous boards including Ryerson University (where he served as Chair), MediSolution Ltd. (member of audit committee), Canada Health Infoway (chair of finance committee), the Canadian Institute for Health Information (CIHI), and the Institute of Clinical Evaluative Sciences (ICES).
Dr. Guerriere received a degree in Medicine and specialty training in Internal Medicine at the University of Toronto. He holds an MBA from the Kellogg School at Northwestern University and an honorary doctorate from Ryerson University.
“On behalf of the Board of Directors, I would like to welcome Michael to our Board and look forward to working with him,” said Alan Torrie, Chairman of Extendicare. “Michael’s diverse background and leadership in medicine, healthcare, and technology provides an excellent complement to our existing Board and will serve as an invaluable asset as we continue to grow across the continuum of seniors’ care,” added Mr. Torrie.ABOUT EXTENDICARE
Extendicare is a leading provider of care and services for seniors throughout Canada. Through our network of 116 operated senior care and living centres (66 owned/50 managed), as well as our home health care operations, we are committed to delivering care throughout the health care continuum to meet the needs of a growing seniors’ population in Canada. Our qualified and highly trained workforce of 23,700 individuals is dedicated to helping people live better through a commitment to quality service and a passion for what we do.Forward-looking Statements
Information provided by Extendicare from time to time, including this release, contains or may contain forward-looking statements concerning anticipated financial events, results, circumstances, economic performance or expectations with respect to Extendicare and its subsidiaries, including, without limitation, statements regarding its business operations, business strategy, and financial condition. Forward-looking statements can be identified because they generally contain the words “anticipate”, “believe”, “estimate”, “expect”, “intend”, “objective”, “plan”, “project”, “will” or other similar expressions or the negative thereof. Forward-looking statements reflect management’s beliefs and assumptions and are based on information currently available, and Extendicare assumes no obligation to update or revise any forward-looking statement, except as required by applicable securities laws. These statements are not guarantees of future performance and involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements of Extendicare to differ materially from those expressed or implied in the statements. Given these risks and uncertainties, readers are cautioned not to place undue reliance on Extendicare’s forward-looking statements. Further information can be found in the disclosure documents filed by Extendicare with the securities regulatory authorities, available at www.sedar.com and on Extendicare’s website at www.extendicare.com. .
For further information, contact:
Jillian E. Fountain
Phone: (905) 470-5534 | Fax: (905) 470-4003
Email: email@example.com| www.extendicare.com.